Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ResMed Inc. Common Stock
(NY:
RMD
)
256.26
-0.80 (-0.31%)
Official Closing Price
Updated: 7:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ResMed Inc. Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,300 Today
↗
April 19, 2023
Via
Benzinga
Expert Ratings for ResMed
↗
April 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
↗
April 14, 2023
Via
Benzinga
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
April 06, 2023
From
ResMed Inc.
Via
GlobeNewswire
$1000 Invested In ResMed 5 Years Ago Would Be Worth This Much Today
↗
April 04, 2023
Via
Benzinga
$100 Invested In ResMed 5 Years Ago Would Be Worth This Much Today
↗
March 17, 2023
Via
Benzinga
$100 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
↗
February 08, 2023
Via
Benzinga
Hopeful Golden Cross Forms On ResMed's Chart
↗
January 26, 2023
Via
Benzinga
ResMed Chief Administrative Officer and Global General Counsel to Retire
March 30, 2023
From
ResMed Inc.
Via
GlobeNewswire
3 Incredible Growth Stocks to Buy Right Now
↗
March 22, 2023
These mid-cap growth stocks could deliver market-beating returns in 2023 and beyond.
Via
The Motley Fool
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
March 15, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
March 13, 2023
From
ResMed Inc.
Via
GlobeNewswire
A Preview Of ResMed's Earnings
↗
January 25, 2023
Via
Benzinga
Where ResMed Stands With Analysts
↗
October 28, 2022
ResMed (NYSE:RMD) has observed the following analyst ratings within the last quarter:
Via
Benzinga
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
January 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
January 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
Earnings Scheduled For January 26, 2023
↗
January 26, 2023
Companies Reporting Before The Bell • Nokia (NYSE:NOK) is estimated to report quarterly earnings at $0.14 per share on revenue of $7.20 billion.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
↗
January 17, 2023
Via
Benzinga
ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
January 12, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
January 02, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
November 22, 2022
From
ResMed Inc.
Via
GlobeNewswire
Looking Into ResMed's Return On Capital Employed
↗
November 01, 2022
According to Benzinga Pro, during Q1, ResMed (NYSE:RMD) earned $210.48 million, a 7.9% increase from the preceding quarter. ResMed also posted a total of $950.29 million in sales, a 3.89% increase...
Via
Benzinga
Company Report Roundup: Tesla, Tractor Supply, American Express, and More
↗
October 29, 2022
Plus a look at investing books, stocks to watch, and other topics for investors.
Via
The Motley Fool
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
October 27, 2022
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
October 13, 2022
From
ResMed Inc.
Via
GlobeNewswire
Earnings Scheduled For October 27, 2022
↗
October 27, 2022
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
↗
October 20, 2022
Upgrades
Via
Benzinga
Silk Road Medical Stock Scores Relative Strength Rating Upgrade
↗
September 28, 2022
Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
↗
October 12, 2022
Upgrades
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
